To view this email as a web page, click here.

Can Antibiotic Therapy for Cancer Improve Treatment Response to Immune Checkpoint Inhibitors?

A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.

Hemithyroidectomy Rates Increase Following Guideline Change

In late 2015, the American Thyroid Association (ATA) changed guideline recommendations trying to rein in overly aggressive treatment of thyroid cancers that are low risk, offering the choice of hemithyroidectomy as an alternative to total thyroidectomy in these patients. In participating hospitals, the rates of hemithyroidectomy went up.

IN CASE YOU MISSED IT

Camrelizumab Plus Chemo Considered as New First-Line Therapy

Findings from the upcoming International Association for the Study of Lung Cancer 2019 World Conference on Lung Cancer show camrelizumab and chemotherapy showed survival benefits for patients with metastatic or otherwise advanced non-squamous non–small-cell lung cancer.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.